GeneDx Holdings Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GeneDx Holdings Corp.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
/ 
Frequently asked questions
To buy GeneDx Holdings Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for GeneDx Holdings Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for GeneDx Holdings Corp. is WGS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
GeneDx Holdings Corp. has its primary listing on NASDAQ. You can trade GeneDx Holdings Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, GeneDx Holdings Corp. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include GeneDx Holdings Corp. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like GeneDx Holdings Corp. or others.